Jianfeng Zhou Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

2/2020	Correction: Soluble B and T Lymphocyte Attenuator Possesses Antitumor Effects and Facilitates Heat Shock Protein 70 Vaccine-Triggered Antitumor Immunity against a Murine TC-1 Cervical Cancer Model In Vivo.
2/2019	Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.
1/2016	Correction: Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters.
4/2015	A novel "priming-boosting" strategy for immune interventions in cervical cancer.
12/2014	Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
8/2013	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
1/2013	HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
1/2013	Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters.
8/2011	The preparation of human papillomavirus type 58 vaccine and exploring its biological activity and immunogenicity in vitro.
1/2011	Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianfeng Zhou Research Topics

Disease

142	Neoplasms (Cancer) 05/2024 - 12/2004
30	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2004
24	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2005
22	Leukemia 01/2022 - 01/2005
21	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2020 - 09/2005
18	Lymphoma (Lymphomas) 01/2023 - 01/2005
16	Multiple Myeloma 10/2023 - 12/2010
15	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 06/2012
13	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 01/2004
12	Carcinogenesis 11/2023 - 07/2005
12	Infections 01/2022 - 02/2014
11	Carcinoma (Carcinomatosis) 01/2022 - 01/2004
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2011
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2018
9	COVID-19 01/2022 - 01/2020
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 08/2012
8	Hemorrhage 02/2022 - 06/2016
8	Breast Neoplasms (Breast Cancer) 01/2014 - 01/2006
6	Hodgkin Disease (Hodgkin's Disease) 04/2024 - 01/2019
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2005
6	Disease Progression 01/2022 - 04/2008
6	Hypoxia (Hypoxemia) 01/2021 - 02/2008
5	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2022
5	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2022 - 04/2016
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2018
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 06/2007
4	Esophageal Neoplasms (Esophageal Cancer) 11/2023 - 01/2021
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2023 - 01/2015
4	Glioma (Gliomas) 08/2023 - 01/2016
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2018
4	Cytokine Release Syndrome 01/2022 - 12/2020
4	Residual Neoplasm 05/2021 - 09/2014
4	Aplastic Anemia (Anemia, Hypoplastic) 02/2014 - 01/2004
4	Lymphatic Metastasis 11/2010 - 03/2008
3	Tumor Lysis Syndrome 03/2024 - 01/2013
3	Hepatoblastoma 02/2024 - 01/2022
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2020
3	Lymphopenia (Lymphocytopenia) 11/2022 - 01/2019
3	Neutropenia 01/2022 - 12/2015
3	Pneumonia (Pneumonitis) 01/2022 - 01/2020
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 01/2020
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 11/2015
3	Virus Diseases (Viral Diseases) 10/2021 - 12/2009
3	Hypertension (High Blood Pressure) 10/2021 - 01/2020
3	Hematologic Diseases (Blood Diseases) 09/2020 - 02/2011
3	Femoral Neck Fractures 04/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

43	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2018
36	Proteins (Proteins, Gene)FDA Link 12/2022 - 07/2004
14	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 07/2004
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2010
12	CytokinesIBA 01/2022 - 01/2009
9	Messenger RNA (mRNA)IBA 12/2022 - 01/2004
9	AntigensIBA 01/2022 - 03/2010
9	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 10/2018
9	Histone Deacetylase InhibitorsIBA 06/2017 - 09/2005
9	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2008
8	zanubrutinibIBA 10/2022 - 01/2020
7	Peptides (Polypeptides)IBA 02/2014 - 01/2006
6	EnzymesIBA 01/2023 - 02/2006
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 10/2006
6	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2020
6	VaccinesIBA 02/2020 - 09/2009
6	theasinensin AIBA 06/2017 - 09/2005
6	trichostatin A (A 300)IBA 06/2017 - 09/2005
6	Phosphotransferases (Kinase)IBA 04/2016 - 01/2005
5	Monoclonal AntibodiesIBA 01/2024 - 06/2012
5	AcidsIBA 11/2023 - 09/2008
5	SurvivinIBA 08/2019 - 07/2005
5	Complementary DNA (cDNA)IBA 11/2011 - 12/2005
4	Therapeutic UsesIBA 02/2024 - 08/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 01/2010
4	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2010
4	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 10/2023 - 01/2017
4	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
4	B-Cell Maturation AntigenIBA 01/2022 - 10/2018
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 10/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 04/2006
4	Ferritins (Ferritin)IBA 07/2020 - 10/2015
4	ElementsIBA 04/2020 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2014
4	Caspase 3 (Caspase-3)IBA 01/2011 - 07/2004
4	Aromatase (CYP19)IBA 02/2006 - 05/2002
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 01/2010
3	Ganciclovir (Cytovene)FDA LinkGeneric 01/2023 - 01/2016
3	Checkpoint Kinase 1IBA 01/2023 - 01/2006
3	Immunoglobulins (Immunoglobulin)IBA 09/2022 - 03/2010
3	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2010
3	Circulating Tumor DNAIBA 05/2021 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 09/2008
3	HMPL-013IBA 01/2021 - 01/2018
3	InterleukinsIBA 01/2020 - 06/2011

Therapy/Procedure

92	Therapeutics 05/2024 - 01/2006
25	Drug Therapy (Chemotherapy) 05/2024 - 07/2004
23	Immunotherapy 04/2024 - 06/2007
11	Stem Cell Transplantation 10/2022 - 01/2015
7	Transplantation 01/2022 - 05/2013
7	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2004
5	Aftercare (After-Treatment) 01/2024 - 01/2005
5	Radiotherapy 01/2022 - 11/2008
4	Neoadjuvant Therapy 11/2023 - 01/2022